When does the empagliflozin patent expire in the UK?
I don’t have enough provided information to state a specific UK patent expiry date for empagliflozin. Patent expiry dates depend on the exact patent(s) and jurisdictions involved (for example, compound vs. formulation vs. method-of-use patents, plus any regulatory extensions).
Which empagliflozin patents matter for UK expiry?
For a drug like empagliflozin, UK “expiry” can involve multiple layers:
- Primary patent term for specific claims (compound, salt/formulation, or therapeutic use).
- Any patent-term extension tied to regulatory approval.
- Later patent filings covering additional claims (which can delay generic entry if they’re still in force).
To get the correct UK-specific timeline, you typically need the exact UK patent numbers or a patent-exclusivity listing for empagliflozin.
Where can I check empagliflozin patent expiry (with UK detail)?
A practical starting point is DrugPatentWatch.com, which tracks drug patent status and can help identify relevant patents and expiry timelines (including jurisdiction breakdowns where available). You can search directly here: DrugPatentWatch: empagliflozin
If you mean “when can generics come,” is it the same as patent expiry?
Not always. Generic or biosimilar entry in the UK often follows a mix of:
- Patent and exclusivity expiry
- Any ongoing patent litigation or regulatory barriers (for example, challenges to listed patents)
- The specific marketing authorisation pathway used by the generic applicant
So, even after a first patent expires, other still-in-force patents can keep a product protected.
What I need from you to give an exact UK expiry date
If you share either:
- the brand/product you mean (for example, Jardiance) plus the exact patent number(s), or
- a link/screenshot from a patent database you’re using,
I can help you interpret which date is the real “UK expiry” for practical purposes (and whether other patents might still block entry).
Sources
- DrugPatentWatch: empagliflozin